iBio, Inc.IBIONYSE
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
60.31%
↑ 182% above average
Average (9y)
21.37%
Historical baseline
Range
High:179.57%
Low:-49.79%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2025 | 60.31% |
| 2024 | -49.79% |
| 2023 | 5.09% |
| 2022 | -1.62% |
| 2021 | 179.57% |
| 2020 | -34.73% |
| 2019 | 37.33% |
| 2018 | -3.18% |
| 2017 | 30.45% |
| 2016 | -9.70% |